Literature DB >> 17394403

Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images.

Håkan Brorson1, Karin Ohlin, Gaby Olsson, Mats Nilsson.   

Abstract

BACKGROUND: Arm lymphedema is a common complication after breast cancer treatment. Various types of conservative and surgical treatments have aimed at reducing the arm swelling, but most of these have failed due to chronic edema eventually being transformed from an accumulation of lymph fluid to an increased deposition of subcutaneous fat (i.e., to a nonpitting lymphedema). Liposuction is a safe and reliable method for reducing the excess fat without recurring deposition of it. The objective of the present study was to obtain empirical evidence confirming clinical observations of the presence of excess adipose tissue in patients with chronic nonpitting arm lymphedema following breast cancer.
METHODS: A total of 11 women with nonpitting unilateral postmastectomy arm lymphedema were investigated and were treated as follows: The patient's excess arm volume was measured by plethysmography (PG) and, following treatment by liposuction, was observed until complete reduction of the excess volume was achieved. Volume-rendered CT images (VR-CT) and PG were used to analyze arm volumes and excess volume of the lympedematous arm, the respective volumes being compared by use of regression analysis. Liposuction aspirate was analyzed in terms of the distribution of adipose tissue and free fluid (lymph). The aspirate volume (total and fat fraction) was compared both with the excess arm volume measured by VR-CT and PG, and with the excess fat volume measured by VR-CT. The amount of excess adipose tissue in the lymphedematous arm was estimated using VR-CT.
RESULTS: A complete reduction of the excess arm volumes, as measured with PG, was achieved within 6 months, with a mean reduction of 109%, the treated arm thus becoming somewhat smaller than the normal one. Correlations in terms of correlation coefficient (CC) and the coefficient of regression (CR) were all close to 1: The preoperative PG and the VR-CT analyses of (a) the swollen arms of the patients and (b) the excess volume; the total aspirated volume, and the excess volume of the arm, the aspirate fat volume, and the excess fat volume. The aspirate removed under bloodless conditions, achieved by use of a tourniquet, contained 93% adipose tissue. VR-CT was able to estimate the amount of excess adipose tissue in the lymphedematous arm, showing a mean excess amount of fat of 81%.
CONCLUSION: VR-CT measurements correlate well with PG measurements. Excess adipose tissue dominates nonpitting chronic arm lymphedema. This excess volume cannot be removed by use either of conservative regimens or of microsurgery. Liposuction can completely remove the excess adipose tissue, leading to complete reduction of the lymphedema.

Entities:  

Mesh:

Year:  2006        PMID: 17394403     DOI: 10.1089/lrb.2006.4404

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  35 in total

1.  Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Authors:  Jamie C Zampell; Sonia Elhadad; Tomer Avraham; Evan Weitman; Seth Aschen; Alan Yan; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

2.  The lymphatics and the inflammatory response: lessons learned from human lymphedema.

Authors:  Stanley G Rockson
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 3.  New developments in clinical aspects of lymphatic disease.

Authors:  Peter S Mortimer; Stanley G Rockson
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

4.  Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI.

Authors:  Manus J Donahue; Paula C M Donahue; Swati Rane; Christopher R Thompson; Megan K Strother; Allison O Scott; Seth A Smith
Journal:  Magn Reson Med       Date:  2015-03-07       Impact factor: 4.668

5.  Lymphoedema and health-related quality of life by early treatment in long-term survivors of breast cancer. A comparative retrospective study up to 15 years after diagnosis.

Authors:  Katarina Y Karlsson; Imke Wallenius; Lena B Nilsson-Wikmar; Henrik Lindman; Birgitta B K Johansson
Journal:  Support Care Cancer       Date:  2015-03-06       Impact factor: 3.603

Review 6.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

7.  Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema.

Authors:  Xiaochen Zhang; Justin C Brown; Electra D Paskett; Babette S Zemel; Andrea L Cheville; Kathryn H Schmitz
Journal:  Breast Cancer Res Treat       Date:  2017-04-08       Impact factor: 4.872

8.  Restoration of lymphatic function rescues obesity in Prox1-haploinsufficient mice.

Authors:  Noelia Escobedo; Steven T Proulx; Sinem Karaman; Miriam E Dillard; Nicole Johnson; Michael Detmar; Guillermo Oliver
Journal:  JCI Insight       Date:  2016-02-25

Review 9.  Liposuction Treatment of Lymphedema.

Authors:  Mark V Schaverien; D Alex Munnoch; Håkan Brorson
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

10.  Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema.

Authors:  Stanley G Rockson; Wen Tian; Xinguo Jiang; Tatiana Kuznetsova; Francois Haddad; Jamie Zampell; Babak Mehrara; Joshua P Sampson; Leslie Roche; Jinah Kim; Mark R Nicolls
Journal:  JCI Insight       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.